Scalper1 News
This week will bring first-quarter earnings reports from four top-rated large-cap drug stocks, and each is expected to report strong growth. On Tuesday before the open, United Therapeutics (UTHR) is expected to report revenue of $353.5 million, up 22% from the year-earlier quarter, according to Thomson Reuters. Earnings are expected to climb 44% to $3.14 a share, though given how much stock-based compensation is included in that figure, analysts Scalper1 News
Scalper1 News